Return to homepagePandemic Pact

Intranasal Universal Respiratory Virus Vaccine

Grant number: RF-TAA-2020-V01

Grant search

Key facts

  • Disease

    N/A

  • Start & end year

    2020
    2021

  • Known Financial Commitments (USD)

    $421,226.4

  • Funder

    RIGHT Foundation

  • Principal Investigator

    Jun Won Youn

  • Research Location

    41

  • Lead Research Institution

    Genexine

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    Innovation

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Development of GX-I7, an engineered IL-7 that induces the proliferation of T-cell which when applied intranasally, recruits adaptive and innate immune cells.